<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01948505</url>
  </required_header>
  <id_info>
    <org_study_id>00061838</org_study_id>
    <nct_id>NCT01948505</nct_id>
  </id_info>
  <brief_title>Effect of IV Acetaminophen on Patients in the Neurocritical Care Unit</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Utah</source>
  <brief_summary>
    <textblock>
      To assess the efficacy of an intravenous nonnarcotic pain medication on controlling patient
      pain.

      To assess the effect of an intravenous nonnarcotic pain medication on patient sedation levels
      in neurocritically ill patients.

      To assess the effect of an intravenous nonnarcotic pain medication on common side effects
      seen in patients taking other intravenous narcotic pain medication in the neurocritical care
      unit.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Level of pain as measured on the 0-10 Numeric Rating Scale (NRS)</measure>
    <time_frame>48 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sedation level as measured on the Riker Scale (1-7)</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Frequency of nausea, vomiting, urinary retention &amp; constipation</measure>
    <time_frame>48 hours</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">210</enrollment>
  <condition>Post-operative Craniotomy Patients</condition>
  <condition>Carotid Endarterectomy and Carotid Artery Stenosis Patients</condition>
  <condition>Post-op Spine Patients Admitted to the NCCU</condition>
  <condition>Endovascular Patients Undergoing Intracranial Intervention</condition>
  <condition>Traumatic Brain Injuries NPO for at Least 12 Hours</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IV acetaminophen: 1000mg IV q 8 hrs (scheduled) until: a) tolerating PO and IV saline-locked or b) 48 hours reached on medication</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>IV Normal Saline: 100ml IV q 8 hrs (scheduled) until: a) tolerating PO and IV saline-locked or b) 48 hours reached on medication</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous acetaminophen</intervention_name>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo for IV acetaminophen</intervention_name>
    <arm_group_label>Placebo Group</arm_group_label>
    <other_name>Normal Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt; 45 kg (amenable to adult dosing)

          -  all traumatic brain injuries NPO for at least 12 hours

          -  all post-operative craniotomy patients

          -  all non-operative subarachnoid hemorrhage, intraparenchymal hemorrhage, and stroke
             patients

          -  all carotid endarterectomy and carotid artery stenosis patients

          -  all endovascular patients undergoing intracranial intervention

          -  all post-op spine patients admitted to the NCCU

        Exclusion Criteria:

          -  documented allergy to acetaminophen

          -  documented severe hepatic impairment (Child-Pugh score &gt; 6) or severe hepatic disease
             (hepatitis)

          -  documented severe renal impairment (CrCl &lt; 30 ml/min) Blood tests will be performed
             prior to study procedures that will ensure patients do not have renal impairment.

          -  patients who are pregnant or breast feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 18, 2013</study_first_submitted>
  <study_first_submitted_qc>September 20, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2013</study_first_posted>
  <last_update_submitted>December 8, 2016</last_update_submitted>
  <last_update_submitted_qc>December 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Utah</investigator_affiliation>
    <investigator_full_name>Walavan Sivakumar</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>Craniotomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Carotid Stenosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>May 7, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

